Factors Predicting Response to Progestin Treatment for Complex Atypical Hyperplasia/Well Differentiated Endometrial Carcinoma in Premenopausal Patients.

被引：0
|
作者：
Aoyama, C.
Penner, K.
Ostrzega, N.
Rao, J.
Walsh, C.
Dorigo, O.
Cass, I.
Balzer, B.
Holschneider, C.
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA USA
[2] UCLA Med Ctr, Los Angeles, CA USA
[3] Cedar Sinai Med Ctr, Los Angeles, CA USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
997
引用
收藏
页码：236A / 236A
页数：1
相关论文
共 50 条
  • [1] Factors Predicting Response to Progestin Treatment for Complex Atypical Hyperplasia/Well Differentiated Endometrial Carcinoma in Premenopausal Patients
    Aoyama, C.
    Penner, K.
    Ostrzega, N.
    Rao, J.
    Walsh, C.
    Dorigo, O.
    Cass, I.
    Balzer, B.
    Holschneider, C.
    MODERN PATHOLOGY, 2011, 24 : 236A - 236A
  • [2] Reporting Responses to Progestin Therapy in Atypical Endometrial Hyperplasia or Well Differentiated Endometrioid Carcinoma
    Lin, Wanrun
    Wang, Yan
    Zhao, Ruijiao
    Wang, Yiying
    Wang, Yue
    Liu, Yuxin
    Zheng, Wenxin
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 789 - 790
  • [3] Reporting Responses to Progestin Therapy in Atypical Endometrial Hyperplasia or Well Differentiated Endometrioid Carcinoma
    Lin, Wanrun
    Wang, Yan
    Zhao, Ruijiao
    Wang, Yiying
    Wang, Yue
    Liu, Yuxin
    Zheng, Wenxin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 789 - 790
  • [4] Efficacy of combinedmetformin and progestin therapy for complex atypical hyperplasia and well-differentiated endometrial cancer in patients desiring fertility
    Acosta-Torres, S.
    Doglioli, M.
    Varghese, A.
    Tanner, E. J., III
    Stone, R. L.
    Levinson, K. L.
    Beavis, A. L.
    Fader, A. N.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 267 - 267
  • [5] Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma
    Kendall, BS
    Ronnett, BM
    Isacson, C
    Cho, KR
    Hedrick, L
    Diener-West, M
    Kurman, RJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (08) : 1012 - 1019
  • [6] Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
    Randall, TC
    Kurman, RJ
    OBSTETRICS AND GYNECOLOGY, 1997, 90 (03): : 434 - 440
  • [7] Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment
    Yang, Yu-Feng
    Liao, Ying-Yang
    Liu, Xian-lian
    Su, Shu-Guang
    Li, Lin-Zhu
    Peng, Ning-Fu
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 419 - 423
  • [8] Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series
    Zakhour, M.
    Cohen, J. G.
    Gibson, A.
    Walts, A. E.
    Karimian, B.
    Baltayan, A.
    Aoyama, C.
    Garcia, L.
    Dhaliwal, S. K.
    Elashoff, D.
    Amneus, M.
    Walsh, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (10) : 1576 - 1583
  • [9] Progestin Treatment of Atypical Hyperplasia and Well-differentiated Adenocarcinoma of the Endometrium to Preserve Fertility
    Koskas, Martin
    Azria, Elie
    Walker, Francine
    Luton, Dominique
    Madelenat, Patrick
    Yazbeck, Chadi
    ANTICANCER RESEARCH, 2012, 32 (03) : 1037 - 1043
  • [10] Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma
    Kudesia, Rashmi
    Singer, Tomer
    Caputo, Thomas A.
    Holcomb, Kevin Michael
    Kligman, Isaac
    Rosenwaks, Zev
    Gupta, Divya
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (03)
12345